Skip to main content

FDA Working Capital Fund

Schedules

TAFS: 075-4613 /X - FDA Working Capital Fund

Iterations:
  • 1: 9/9/26 (this iteration)
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionAmountFootnotes
1000DEDiscretionary Excepted - Unob Bal: Brought forward, Oct 1 $136,906,392
1061Unob Bal: Antic recov of prior year unpd/pd obl $34,500,000
1740BA: Disc: Spending auth:Antic colls, reimbs, other $1,713,022,833
1920Total budgetary resources avail (disc. and mand.) $1,884,429,225
6001Category A -- 1st quarter $563,787,850
6002Category A -- 2nd quarter $751,898,625
6003Category A -- 3rd quarter $488,135,750
6004Category A -- 4th quarter $80,607,000
6190Total budgetary resources available $1,884,429,225See footnotes below
Footnotes for line 6190:

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections and recoveries received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections and recoveries received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.